CD8A and neoplasm: Our results demonstrated that tumor-infiltrating CD8+ T cells were featured by decreased Tpredys cells and increased Tdys cells, driven by a special immunosuppressive microenvironment, which prompted us to consider whether it is appropriate to give anti-PD-(L)1 perioperative immunotherapy in all PD-L1>1% patients with LNM.